Search

Your search keyword '"Bromfenac -- Intellectual property"' showing total 26 results
Start Over Descriptor "Bromfenac -- Intellectual property"
26 results on '"Bromfenac -- Intellectual property"'

4. Patent Application Titled 'Ophthalmic Drug Sustained Release Formulation And Uses Thereof' Published Online (USPTO 20230091568)

Subjects
Patient compliance, Ophthalmic drugs -- Intellectual property, Fluocinolone acetonide, Nepafenac, Difluprednate, Fluocinolone, Bromfenac -- Intellectual property, Physical fitness, Health
Abstract

2023 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2023

5. Researchers Submit Patent Application, 'Powder Mixing Device, And Uses Thereof', for Approval (USPTO 20240041773)

Subjects
Nandrolone -- Intellectual property, Droperidol, Bupivacaine -- Intellectual property, Levetiracetam -- Intellectual property, Hydroxyprogesterone -- Intellectual property, Dexmedetomidine -- Intellectual property, Lacosamide -- Intellectual property, Ethylenediaminetetraacetic acid -- Intellectual property, Brompheniramine -- Intellectual property, Nalbuphine -- Intellectual property, Pantoprazole -- Intellectual property, Bromfenac -- Intellectual property, Business, Health
Abstract

2024 MAR 1 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Patent Business Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors [...]

Published
2024

6. 'Ophthalmic Drug Compositions' in Patent Application Approval Process (USPTO 20230355431)

Subjects
Temsirolimus, Corticosteroids -- Intellectual property, Medrysone -- Intellectual property, Epinastine -- Intellectual property, Olopatadine hydrochloride -- Intellectual property, Ciclesonide, Nepafenac, Adalimumab -- Intellectual property, Drug approval, Bromfenac -- Intellectual property, Government, Political science
Abstract

2023 NOV 30 (VerticalNews) -- By a News Reporter-Staff News Editor at Politics & Government Week -- A patent application by the inventors Bley, Robert Steven (Menlo Park, CA, US); [...]

Published
2023

7. Patent Issued for Ocular Drug Delivery System And Uses (USPTO 10,966,955)

Subjects
Besifloxacin, Drugs -- Vehicles, Ophthalmic drugs -- Intellectual property, Nepafenac, Bromfenac -- Intellectual property, Drug delivery systems -- Intellectual property, Physical fitness, Health
Abstract

2021 APR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A patent by the inventors Lai, Jui-Yang (Taoyuan, TW); Luo, Li-Jyuan (Taoyuan, [...]

Published
2021

9. Patent Application Titled 'Combination Of An Antimuscarinic Or An Anticholinergic Agent And Lipoic Acid And Uses Thereof' Published Online (USPTO 20200375961)

Subjects
Cevimeline, Nepafenac, Amino acids -- Intellectual property, Bromfenac -- Intellectual property, Physical fitness, Health
Abstract

2020 DEC 26 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a [...]

Published
2020

12. Patent Issued for Ophthalmic drug sustained release formulation and uses thereof (USPTO 11324693)

Subjects
Medical equipment -- Intellectual property, Ophthalmic drugs -- Intellectual property, Fluocinolone acetonide, Nepafenac, Difluprednate, Fluocinolone, Physiological apparatus -- Intellectual property, Bromfenac -- Intellectual property, Health, Health care industry
Abstract

2022 JUN 5 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, [...]

Published
2022

13. Patent Application Titled 'D2o Stabilized Pharmaceutical Formulations' Published Online (USPTO 20210393649)

Subjects
Povidone -- Intellectual property, Antihistamines -- Intellectual property, Bromfenac -- Intellectual property, Levobetaxolol -- Intellectual property, Besifloxacin, Neomycin -- Intellectual property, Corticosteroids -- Intellectual property, Medrysone -- Intellectual property, Olopatadine hydrochloride -- Intellectual property, Ophthalmic drugs -- Intellectual property, Ethylenediaminetetraacetic acid -- Intellectual property, Nepafenac, Parasympatholytic agents -- Intellectual property, Trifluridine -- Intellectual property, Health
Abstract

2022 JAN 12 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by [...]

Published
2022

14. 'D2o Stabilized Pharmaceutical Formulations' in Patent Application Approval Process (USPTO 20210283142)

Subjects
Povidone -- Intellectual property, Antihistamines -- Intellectual property, Bromfenac -- Intellectual property, Levobetaxolol -- Intellectual property, Besifloxacin, Corticosteroids -- Intellectual property, Medrysone -- Intellectual property, Olopatadine hydrochloride -- Intellectual property, Ophthalmic drugs -- Intellectual property, Ethylenediaminetetraacetic acid -- Intellectual property, Nepafenac, Parasympatholytic agents -- Intellectual property, Trifluridine -- Intellectual property, Health
Abstract

2021 OCT 6 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A patent application by the inventors BAKER, David S. (Carlsbad, CA, US); OSTROW, Gregory I. [...]

Published
2021

15. Patent Issued for D2O stabilized pharmaceutical formulations (USPTO 11052095)

Subjects
Povidone -- Intellectual property, Antihistamines -- Intellectual property, Bromfenac -- Intellectual property, Levobetaxolol -- Intellectual property, Besifloxacin, Neomycin -- Intellectual property, Corticosteroids -- Intellectual property, Medrysone -- Intellectual property, Olopatadine hydrochloride -- Intellectual property, Ophthalmic drugs -- Intellectual property, Ethylenediaminetetraacetic acid -- Intellectual property, Nepafenac, Parasympatholytic agents -- Intellectual property, Trifluridine -- Intellectual property, Health
Abstract

2021 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A patent by the inventors Baker, David S. (Carlsbad, CA, US), Ostrow, Gregory I. (San [...]

Published
2021

16. 'Ocular Drug Delivery System And Uses Thereof' in Patent Application Approval Process (USPTO 20210059980)

Subjects
Besifloxacin, Drugs -- Vehicles, Ophthalmic drugs -- Intellectual property, Nepafenac, Bromfenac -- Intellectual property, Drug delivery systems -- Intellectual property, Health
Abstract

2021 MAR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- A patent application by the inventors Lai, Jui-Yang (Taoyuan City, TW); Luo, Li-Jyuan (Taoyuan [...]

Published
2021

17. 'Treatment Of Ocular Diseases With Ophthalmic Tapinarof Compositions' in Patent Application Approval Process (USPTO 20210000758)

Subjects
Eye diseases, Ophthalmic drugs -- Intellectual property, Macular degeneration, Nepafenac, Adalimumab -- Intellectual property, Bromfenac -- Intellectual property, Etoricoxib, Health
Abstract

2021 JAN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- A patent application by the inventors ARKIN, Moshe (Kfar Shmaryahu, IL); ZIGHELBOIM, Marcel (Kiryat Motzkin, [...]

Published
2021

18. Researchers Submit Patent Application, 'Pharmaceutical Compositions Comprising An Integrin Alpha4 Antagonist For Use In Treating Ocular Inflammatory Conditions', for Approval (USPTO 20200405703)

Subjects
Corticosteroids -- Intellectual property, Eye diseases, Nepafenac, Bromfenac -- Intellectual property, Health
Abstract

2021 JAN 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventor [...]

Published
2021

19. Researchers Submit Patent Application, 'Treatment Of Ocular Diseases With Ophthalmic Tapinarof Compositions', for Approval (USPTO 20200390725)

Subjects
Eye diseases, Ophthalmic drugs -- Intellectual property, Macular degeneration, Nepafenac, Adalimumab -- Intellectual property, Bromfenac -- Intellectual property, Etoricoxib, Health
Abstract

2021 JAN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors ARKIN, Moshe [...]

Published
2021

20. 'Treatment Of Ocular Diseases With Ophthalmic Tapinarof Compositions' in Patent Application Approval Process (USPTO 20200390724)

Subjects
Eye diseases, Ophthalmic drugs -- Intellectual property, Macular degeneration, Nepafenac, Adalimumab -- Intellectual property, Bromfenac -- Intellectual property, Etoricoxib, Health
Abstract

2021 JAN 4 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- A patent application by the inventors ARKIN, Moshe (Kfar Shmaryahu, IL); ZIGHELBOIM, Marcel (Kiryat Motzkin, [...]

Published
2021

22. Researchers Submit Patent Application, 'COX-2 Inhibitors For The Treatment Of Ocular Disease', for Approval (USPTO 20200237715)

Subjects
COX-2 inhibitors, Macular degeneration, Ranibizumab, Bevacizumab -- Intellectual property, Bromfenac -- Intellectual property, Sunitinib, Blindness, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

2020 AUG 19 (NewsRx) -- By a News Reporter-Staff News Editor at Biotech Week -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Vrbanac, JR., [...]

Published
2020

23. Patent Application Titled 'Eye Drops For Treating Dry Eye' Published Online (USPTO 20190365685)

Subjects
Ophthalmic agents -- Intellectual property, Bromfenac -- Intellectual property, Povidone -- Intellectual property, Technology, Medical equipment, Chronic diseases, Editors, Health, Health care industry
Abstract

2019 DEC 29 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, [...]

Published
2019

24. 'Eye Drops For Treating Dry Eye' in Patent Application Approval Process (USPTO 20190365686)

Subjects
Ophthalmic agents -- Intellectual property, Bromfenac -- Intellectual property, Povidone -- Intellectual property, Technology, Medical equipment, Chronic diseases, Editors, Health, Health care industry
Abstract

2019 DEC 29 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- A patent application by the inventors TAKAHASHI, Yuji (Tokyo, JP); MIZUSHIMA, [...]

Published
2019

25. Researchers Submit Patent Application, 'Ophthalmic Drug Delivery', for Approval (USPTO 20190074086)

Subjects
Zinc sulfate -- Intellectual property, Bromfenac -- Intellectual property, Olopatadine -- Intellectual property, Drug delivery systems -- Intellectual property, Difluprednate, Nepafenac, Loteprednol -- Intellectual property, Ophthalmic agents -- Intellectual property, Besifloxacin, Bepotastine, Drug approval, Tromethamine -- Intellectual property, Bevacizumab -- Intellectual property, Ranibizumab, Ocriplasmin, Travoprost, Editors, Pegaptanib, Immunotherapy, Brinzolamide, Bimatoprost, Health
Abstract

2019 MAR 27 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- From Washington, D.C., NewsRx journalists report that a patent application by the inventors Ballou, JR., [...]

Published
2019

26. 'Treatment And Diagnosis Of Ocular Surface Disorders' in Patent Application Approval Process (USPTO 20190000871)

Subjects
Fidaxomicin, Tetracycline -- Intellectual property, Corticosteroids -- Intellectual property, Eye diseases, Medrysone -- Intellectual property, Nepafenac, Bromfenac -- Intellectual property, Tetracyclines -- Intellectual property, Pharmaceuticals and cosmetics industries
Abstract

2019 JAN 25 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- A patent application by the inventors Jain, Sandeep (Oak Park, IL); Musunuri, Karthik (Chester Springs, [...]

Published
2019

Catalog

Books, media, physical & digital resources
See catalog results